规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
---|---|---|---|---|---|---|---|---|---|
100mg | ¥ ǶȬȁȻȁȁ | > 10 | > 10 | -- | -- | 2 | -- | ¥ ǶȬȁȻȁȁ | - + |
250mg | ¥ ljǫɆȻȁȁ | > 10 | > 10 | -- | -- | -- | 1 | ¥ ljǫɆȻȁȁ | - + |
1g | ¥ ƏljƏȻȁȁ | 10 | > 10 | -- | -- | -- | 1 | ¥ ƏljƏȻȁȁ | - + |
5g | ¥ ǫǶljɆȻȁȁ | 2 | 9 | -- | -- | -- | -- | ¥ ǫǶljɆȻȁȁ | - + |
10g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
25g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
100g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
产品编号
1187584
CAS 号
2010-15-3
中文名称
3-苯基-2-硫代氧杂咪唑啉-4-酮
MDL 号
MFCD00027413
分子量
192.23762
存储条件
2-8°C
网页展示纯度为入库指导纯度值,各批次间存在一定差异,实际纯度以收货为准
熔点
257 °C
沸点
292.1±23.0 °C at 760 mmHg
闪点
旋光
描述
TPSA
32.34
LogP
0.9077
H_Acceptors
2
H_Donors
1
Rotatable_Bonds
1
[1]. Alfredo Berruti, et al. Enzalutamide in prostate cancer after chemotherapy. N Engl J Med. 2012 Dec 20;367(25):2448; author reply 2448-9.
[2]. David End, et al. Interactions of abiraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: a rationale for increasing abiraterone exposure or combining with MDV3100. Cancer Res. 2013 May 1;73(9):2926.
[3]. Fernand Labrie, et al. Combined blockade of testicular and locally made androgens in prostate cancer: a highly significant medical progress based upon intracrinology. J Steroid Biochem Mol Biol. 2015 Jan:145:144-56.
[4]. I Ouzaid, et al. [Novel agents for the therapy of castration-resistant prostate cancer: overview of pivotal studies and new strategies to come]. Prog Urol. 2013 Jan;23(1):1-7.
[5]. Julie N Graff, et al. Complete biochemical (prostate-specific antigen) response to sipuleucel-T with enzalutamide in castration-resistant prostate cancer: a case report with implications for future research. Urology. 2013 Feb;81(2):381-3.
警示图
警示词
Danger
危险申明
H301-H311-H331
警告申明
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P361-P363-P405-P501
GHS 编码
GHS06
危险类别
6.1
UN 编码
2811
包装等级
Ⅲ
展开更多
现货供应
专业护航
售后无忧
品质保障
无需凑单